Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
2014
Mechanisms underlying kainate receptor-mediated disinhibition in the hippocampus
1999
The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease
2011 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Recurrent Circuits in Layer II of Medial Entorhinal Cortex in a Model of Temporal Lobe Epilepsy
2007
Recurrent inhibitory circuitry as a mechanism for grid formation
2013 StandoutNobel
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Critical period plasticity in local cortical circuits
2005 Standout
Understanding Synapses: Past, Present, and Future
2008 StandoutNobel
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
2017
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
2018
Parkinson's disease
2021 Standout
Dendritically Released Peptides Act as Retrograde Modulators of Afferent Excitation in the Supraoptic Nucleus In Vitro
1997
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Grid cells in pre- and parasubiculum
2010 StandoutNobel
Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
2007 Standout
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Computational Models of Grid Cells
2011 StandoutNobel
Modulation of spontaneous quantal release of neurotransmitters in the hippocampus
2001
RIM1α and RIM1β Are Synthesized from Distinct Promoters of theRIM1Gene to Mediate Differential But Overlapping Synaptic Functions
2008 StandoutNobel
Endocannabinoid‐mediated short‐term synaptic plasticity: depolarization‐induced suppression of inhibition (DSI) and depolarization‐induced suppression of excitation (DSE)
2004
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling
2004
ELKS2α/CAST Deletion Selectively Increases Neurotransmitter Release at Inhibitory Synapses
2009 StandoutNobel
The Presynaptic Active Zone
2012 StandoutNobel
Monosodium urate monohydrate crystals inhibit osteoblast viability and function: implications for development of bone erosion in gout
2011
Theta Oscillations in the Hippocampus
2002 Standout
Cannabinoid Receptor Signaling
2005
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids
2002
Synaptotagmin-12 Phosphorylation by cAMP-Dependent Protein Kinase Is Essential for Hippocampal Mossy Fiber LTP
2013 StandoutNobel
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Presynaptic, Activity-Dependent Modulation of Cannabinoid Type 1 Receptor-Mediated Inhibition of GABA Release
2006
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
2018
Parkinson's disease
2015 Standout
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Dual intracellular recordings and computational models of slow inhibitory postsynaptic potentials in rat neocortical and hippocampal slices
1999
Presynaptic Modulation by Endocannabinoids
2007
Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex
2000
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Alzheimer's disease
2016 Standout
Cannabis and the brain
2003
Endocannabinoids facilitate the induction of LTP in the hippocampus
2002
Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease: A Systematic Review and Meta-Analysis
2018
Endocannabinoid Signaling Dynamics Probed with Optical Tools
2005
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
A dual-Ca2+-sensor model for neurotransmitter release in a central synapse
2007 StandoutNatureNobel
LTP and LTD
2004 Standout
The molecular logic of endocannabinoid signalling
2003 Standout
Alzheimer's disease: clinical trials and drug development
2010
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
2016
Miniature Synaptic Events Elicited by Presynaptic Ca2+ Rise Are Selectively Suppressed by Cannabinoid Receptor Activation in Cerebellar Purkinje Cells
2006
Non-motor features of Parkinson disease
2017 Standout
Retrograde signaling by endocannabinoids
2002
Gastrointestinal dysfunction in Parkinson's disease
2015
RIM Proteins Activate Vesicle Priming by Reversing Autoinhibitory Homodimerization of Munc13
2011 StandoutNobel
Synaptic activation of kainate receptors on hippocampal interneurons
1998
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Interneurons of the neocortical inhibitory system
2004 Standout
Long‐term potentiation of GABAergic synaptic transmission in neonatal rat hippocampus
1999
Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells
2001
Photolysis‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons
2001
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
2001
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
2005
Excitatory actions of gaba during development: the nature of the nurture
2002 Standout
A Sensitive Aβ Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
2014
A Resource of Cre Driver Lines for Genetic Targeting of GABAergic Neurons in Cerebral Cortex
2011 Standout
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
THE SYNAPTIC VESICLE CYCLE
2004 StandoutNobel
A new form of cerebellar long-term potentiation is postsynaptic and depends on nitric oxide but not cAMP
2002 StandoutNobel
Evidence for Metabotropic Glutamate Receptor Activation in the Induction of Depolarization-Induced Suppression of Inhibition in Hippocampal CA1
1998
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
2001 Nature
Endocannabinoid Signaling and Long-Term Synaptic Plasticity
2009
Mechanisms of Induction and Expression of Long-Term Depression at GABAergic Synapses in the Neonatal Rat Hippocampus
1999
Role of Endogenous Cannabinoids in Synaptic Signaling
2003
Characterization of Depolarization-Induced Suppression of Inhibition Using Paired Interneuron–Purkinje Cell Recordings
2003
Short-Term Synaptic Plasticity
2002 Standout
Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease
2018
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Potassium Conductance Causing Hyperpolarization of CA1 Hippocampal Neurons During Hypoxia
1998
RIM genes differentially contribute to organizing presynaptic release sites
2012 StandoutNobel
Gout
2021 Standout
The role of calcitonin gene–related peptide in peripheral and central pain mechanisms including migraine
2017
Coexistence of Functional IP3and Ryanodine Receptors in Vagal Sensory Neurons and Their Activation by ATP
2002
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
2018
Activation of Muscarinic Acetylcholine Receptors Enhances the Release of Endogenous Cannabinoids in the Hippocampus
2002
Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus
2001
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
2006
Endocannabinoids Mediate Rapid Retrograde Signaling At Interneuron → Pyramidal Neuron Synapses of the Neocortex
2003
Functional Significance of Cannabinoid-Mediated, Depolarization-Induced Suppression of Inhibition (DSI) in the Hippocampus
2003
Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men
2014
The Membrane Fusion Enigma: SNAREs, Sec1/Munc18 Proteins, and Their Accomplices—Guilty as Charged?
2012 StandoutNobel
RIM1α phosphorylation at serine-413 by protein kinase A is not required for presynaptic long-term plasticity or learning
2008 StandoutNobel
Physiology of Microglia
2011 Standout
The future of blood‐based biomarkers for Alzheimer's disease
2013
Works of Robert Lenz being referenced
Calcium dependence of depolarization‐induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons
1999
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2017
Response of human osteoblasts exposed to wear particles generated at the interface of total hip stems and bone cement
2008
Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
2013
Cerebrospinal Fluid Cytokine Dynamics Differ Between Alzheimer Disease Patients and Elderly Controls
2011
N‐ and L‐type calcium channel involvement in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells
1998
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
2013
Presynaptic factors in the regulation of DSI expression in hippocampus
2002
N-Ethylmaleimide Blocks Depolarization-Induced Suppression of Inhibition and Enhances GABA Release in the Rat Hippocampal SliceIn Vitro
1997
Effect of human cerebrospinal fluid sampling frequency on amyloid‐β levels
2011
Retrograde signalling in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells.
1996
P2‐221: ABT‐089, a neuronal nicotinic receptor partial agonist, reverses scopolamine‐induced cognitive deficits in healthy normal subjects
2009
N-ethylmaleimide blocks depolarization-induced suppression of inhibition and enhances GABA release in the rat hippocampal slice in vitro.
1997
High Intracellular Cl−Concentrations Depress G-Protein-Modulated Ionic Conductances
1997